Johnson & Johnson (NYSE:JNJ) and Eli Lilly (NYSE:LLY) are utilizing Nvidia (NVDA) technology to either enhance their products ...
Johnson & Johnson’s medical technology unit and its health data company Verily have penned separate new deals with technology ...
National Security Journal on MSN
China’s J-20 Mighty Dragon Stealth Fighter Suffers from a Key ‘Deficit’
Key Points and Summary – Despite China’s J-20 “Mighty Dragon” having formidable on-paper specs—including Mach 2.0 speed, a ...
Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to ...
Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis.
Pharmaceutical Technology on MSN
ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory
J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...
Summary and Key Points: The Chengdu J-20 Mighty Dragon, China’s first fifth-generation stealth fighter, has raised suspicions of incorporating American technology. -Following its 2011 debut, questions ...
Experts have recently warned that the PLAAF 5th gen fighter, thanks to the espionage efforts, is more advanced than it otherwise would be. But the real question is: has China been able to catch up?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback